STAAR Surgical Company (STAA)

Market Cap	1.40B
Revenue (ttm)	224.45M
Net Income (ttm)	-95.27M
Shares Out	49.55M
EPS (ttm)	-1.93
PE Ratio	n/a
Forward PE	104.87
Dividend	n/a
Ex-Dividend Date	n/a

Volume	3,285,368
Open	27.45
Previous Close	27.39
Day's Range	27.42 - 30.81
52-Week Range	13.50 - 39.35
Beta	0.62
Analysts	Hold
Price Target	22.50 (-20.24%)
Earnings Date	Aug 6, 2025

About STAA

STAAR Surgical Company, together with its subsidiaries, designs, develops, manufactures, and sells implantable lenses for the eye and accessory delivery systems to deliver the lenses into the eye. The company provides implantable Collamer lens product family (ICLs) and laser-based procedures, such as LASIK to treat visual disorders, such as myopia, hyperopia, astigmatism, and presbyopia. It serves its products to health care providers, including ophthalmic surgeons, vision and surgical centers, hospitals, government facilities, and distributors...

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• Founded: 1982
• Employees: 1,157
• Stock Exchange: NASDAQ
• Ticker Symbol: STAA
• Website: https://www.staar.com

Analyst Forecast

According to 8 analysts, the average rating for STAA stock is "Hold." The 12-month stock price target is $22.5, which is a decrease of -20.24% from the latest price.

Price Target

$22.5

(-20.24% downside)

Analyst Consensus: Hold